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Nanotechnology has been applied in consumer products and commercial applications,
showing a significant impact on almost all industries and all areas of society. Significant
evidence indicates that manufactured nanomaterials and combustion-derived nano-
materials elicit toxicity in humans exposed to these nanomaterials. The interaction of the
engineered nanomaterials with the nervous system has received much attention in the
nanotoxicology field. In this review, the biological effects of metal, metal oxide, and
carbon-based nanomaterials on the nervous system are discussed from both in vitro and
in vivo studies. The translocation of the nanoparticles through the bloodebrain barrier or
nose to brain via the olfactory bulb route, oxidative stress, and inflammatory mechanisms
of nanomaterials are also reviewed.
Copyright ª 2014, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license. 1. Introduction
As a rapidly growing emerging science, nanotechnology has
shown a significant impact on almost all industries and all
areas of society. Nanomaterials, defined by the National
Nanotechnology Initiative, have at least one dimension in
the range of 1e100 nm. Due to their small size, the properties
of nanomaterials may differ from those of their bulk mate-
rials, showing unique chemical, physical, optical, and elec-
trical properties. Nanotechnology involves creating and
applying engineered materials at the nanoscale to take
advantage of these specific properties. Humans have been
exposed to many nanoparticles (NPs) originating fromose of the authors and d
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diseases such as Alzheimer’s disease, Parkinson’s disease, or
Huntington’s disease have been diagnosed and treated. The
increased amount of environmental pollutants, including
NPs, may be responsible for increasing the number of these
neurodegenerative diseases. The role of the bloodebrain
barrier (BBB) is crucial in understanding NP toxicity in the
brain. BBB separates blood from cerebrospinal fluid in the
central nervous system (CNS). The BBB is an extended plasma
membrane that contains tight junctions between the adjacent
endothelial cells of the cerebral capillaries. The permeability
properties of the BBB are of interest [1,11]. Unlike noncerebral
capillaries, the cerebral endothelium does not have vesicles
for macromolecular transport. Astrocytic end feet cover most
(85%) of the cerebral capillary endothelial cells and they also
contain a thick basement membrane [12]. The presence of
such complex combinations of astrocytes, cerebral capillaries
and basement membrane strongly supports the BBB function
[11,13], even though establishing the clear cut roles of the
basal lamina and/or astrocytic end feet in maintaining BBB
permeability needs further study. When NPs reach the circu-
lation, they may interfere with the function of the endothelial
cell membrane. The effect of NPs on the cell membrane may
be due to their direct toxicity, or indirectly, they may induce
some cascade mechanism that disrupts the tight junctions in
the BBB or alters the permeability of the membrane. It has
been shown that intravenous, intraperitoneal, or intracerebral
administration of Ag, Cu, or Al NPs (50e60 nm) reportedly
disrupts the BBB, as indicated by stainingwith albumin-bound
Evans blue [14]. Vesicular transport may also be stimulated by
NPs in order to gain access to the CNS microenvironment to
exert toxic effects in the CNS. The unique size and surface
modification of NPs could deliver drugs or therapeutic agents
to the brain in the development of nanomedicine. Additional
research is, however, necessary in order to understand fully
how NPs are translocated from the blood to the brain across
the BBB.
Nanomaterials could enter the human body by different
routes including inhalation, dermal penetration, ingestion,
and systemic administration, by which NPs may be accumu-
lated in different tissues and organs including the brain
[15,16]. It has been indicated that the olfactory nerve pathway
may serve as a portal of entry for NPs into the CNS in humans
who are environmentally or occupationally exposed to
airborne NPs [17e19]. De Lorenzo [18] showed that when
silver-coated colloidal gold particles (50 nm) were intranasally
instilled in squirrel monkeys, the NPs anterogradely moved in
the axons of the olfactory nerve to the olfactory bulbs. Olfac-
tory epithelium that has been exposed to manganese, cad-
mium, nickel, and cobalt nanomaterials can translocate the
nanomaterials to the brain via olfactory neurons [20e25].
Therefore, full understanding of the neurotoxicity of these
nanomaterials may lead to the design of safer therapeutics
and reduce the side effects of these nanomaterials in future.
Having a greater surface area than their bulk counterparts,
metal oxide NPs are used in various fields such as water
treatment, medicine, cosmetics, and engineering, and provide
superior performance in their applications. Unfortunately,
almost no federal or state laws have specifically established
regulations for the manufacture, transportation, use, sale, ordisposal of nanomaterials [26]. For metal oxide NPs, their
widespread application, small size, and large specific surface
area endow them with high chemical reactivity and intrinsic
toxicity, and their health effects in living creatures, especially
on the nervous system, have been of concern. Metal oxide NPs
are capable of translocating along the olfactory nerve pathway
to the brain after intranasal instillation, and accumulating in
the olfactory bulb, cortex, and cerebellum. Moreover, NP
deposition in the brain can stimulate oxidative stress, in-
flammatory responses, and pathological changes. These ob-
servations have provided evidence that metal oxide NPs can
reach the brain and cause a certain degree of tissue damage.
Metal oxide toxicity can also be induced by dissolvedmetal
ions from the oxides. Brunner et al [27] studied the toxicity of
NPs in human and rodent cell lines. They divided the tested
NPs into soluble and insoluble NPs, and showed that the
toxicity of soluble NPs was from the soluble metal ions
released from NP dissolution prior to or after the NPs entered
the neural cells. Considering the unique physicochemical
properties, including small size effect, large specific surface
area, and high biological surface reactivity, NPs might induce
the neurotoxicological behavior and effects in organisms.2. Neurotoxicity and mechanism of
nanomaterials
2.1. Titanium dioxide NPs
Among several metal-based NPs, those originating from tita-
nium have been used widely and in large quantities. Titanium
dioxide (TiO2) is themost common compound of titanium that
has found a variety of uses in our lives. TiO2 is a white,
odorless, water-insoluble material that was believed to have
low toxicity [28e31]. TiO2 is a relatively stable, nonflammable
material that is found naturally in the form of various ores
such as rutile, anatase, and brookite. TiO2 can also be
extracted from an iron-containing mineral (FeTiO3) known as
ilmenite [32e36]. TiO2 possesses certain physiochemical
properties that make it useful for multiple applications.
Corrosion resistance, biocompatibility, mechanical strength,
whitening property, opacity, and photocatalytic, optical, and
electrical activity are some of the attractive properties that
have paved the way for large-scale applications of TiO2 [37].
The National Nanotechnology Initiative of America classifies
nanoparticulate TiO2 particles as one of most widely manu-
factured NPs globally [38].
Industrially, 80% of TiO2, including its nanoparticulate
form (globally), is used to produce paints, varnishes, plastic,
and papers. Besides these applications, nanoparticulate TiO2
has major uses in developing various products such as cos-
metics, foodstuffs, toothpaste, sun blocks, printing ink, car
materials, rubber, cleaning products, materials for industrial
photocatalytic applications including solar cells, and catalysts
for remediation of organic matter in wastewater [39]. Toxicity
of nanosized TiO2 has yet to be completely understood despite
its widespread uses. Recent toxicological studies have indi-
cated harmful effects of TiO2 NPs in biological systems, which
is of major concern [40]. It has been recently recognized that
TiO2 may be carcinogenic to humans if inhaled [31]. As a
j o u r n a l o f f o o d and d ru g an a l y s i s 2 2 ( 2 0 1 4 ) 1 4 7e1 6 0 149result, it is of great importance to understand the risks and
hazards including neurotoxicity associated with nano-
particulate TiO2 exposure and its dose-dependent response
[41]. Irrespective of the different forms of TiO2, exposure route
and particle size, it has been found that TiO2 NPs translocate
to different parts of the brain [39,42e46]. The NPs accumulate
in this organ and induce structural changes in the neuronal
architecture [39,43,45]. As mentioned previously, when NPs
are inhaled, they can translocate to the CNS using the olfac-
tory nerve as a means of entry. Several studies in mice have
indicated that rutile NPs can translocate to the brain and
accumulate throughout the organ, primarily in the hippo-
campus regions [39,43,45]. Such a neuronal translocation
pathway of TiO2 NPs may be responsible for neurotoxicity.
TiO2 NPs when instilled intratracheally in mice accumulate in
the brain via the blood circulation and penetration of the BBB.
This type of accumulation is responsible for inducing tissue
damage [42]. Accumulation of nanoparticulate TiO2 in the
brain induces release and metabolism of neurotransmitters
such as norepinephrine and 5-hydroxytryptamine
[39,43,45,46]. After intranasal exposure of TiO2 NPs,
enhanced levels of the above-mentioned compounds were
detected [43]. However, a decrease in response was detected
when anatase TiO2 NPs were administered intragastrically
[45]. Reduced levels of homovanillic acid, dopamine, 5-
hydroxyindole acetic acid, and 3,4-dihydroxyphenylacetic
acid were detected when TiO2 NPs were administered intra-
nasally or intragastrically [43,46]. Enhanced catalase and
acetylcholinesterase activity was detected during intranasal
instillation of rutile [39] and intragastric administration of
anatase TiO2 NPs [46]. Acetylcholine, glutamic acid, soluble
protein carbonyl, and nitric oxide content were also increased
by such NP treatments. When anatase TiO2 NPs were intra-
peritoneally injected, increased nitric oxide but decreased
acetylcholine and glutamic acid were detected [44]. Hu and
colleagues [46] showed that the levels of sodium, potassium,
magnesium, calcium, iron, and zinc in the brainwere changed
after nanoparticulate TiO2 exposure. In that study, the treated
mice had impaired spatial recognition memory, which could
be linked to the disturbed homeostasis of neurotransmitters,
trace elements, and enzymes in the brain [46]. Proteomic
analysis showed differentially expressed proteins in the brain
in response to TiO2 NP exposure, even though no NPs were
detected in the tissue [47]. Oxidative-stress-related damage
with a consequent change in the balance between oxidative
and antioxidative activities was observed both in vitro [48e50]
and in vivo [39,42,44,45,47]. Levels of malondialdehyde, an
oxidativemarker, increased after intranasal instillation [39,44]
of TiO2 NPs. A similar effect was also found with intra-
abdominal injection and intratracheal instillation of TiO2
NPs in mice [42]. Reactive oxygen species (ROS) such as su-
peroxide [42], hydrogen peroxide [42,45], and hydroxyl radical
[42] were also found to be increased in animals treated with
TiO2 NPs. Increased cytokine levels, which are indicative of
inflammatory effects in the brain, were detected in animals
treated with TiO2 NPs [44,51]. TiO2 NPs (P25 Degussa TiO2 and
rutile forms) when injected intraperitoneally in mice induce
an increase in lipopolysaccharides, and alter the mRNA levels
of interleukin IL-1b and tumor necrosis factor (TNF)-a, as well
as IL-1b protein. Lipopolysaccharide induction was necessaryto cause this phenomenon, which suggests the importance of
a trigger element or a possible synergistic role in tissue re-
sponses to nanoparticulate TiO2. The embryotoxic role of TiO2
was also studied by maternal intravenous injection of TiO2
NPs, which yielded no characterized TiO2 NPs [52], and by
subcutaneous injection of TiO2 NPs in the anatase form
[53e55].
In the case of subcutaneous injections, TiO2 accumulation
was found in the offspring cerebral cortex and olfactory bulb.
A large number of olfactory bulb cells were found to be posi-
tive formarkers of apoptosis [53]. Altered gene expressionwas
detected for prenatal TiO2 NP exposure, whichwas involved in
cell death, brain development, and the response to oxidative
stress in newborn pups [54]. Finally, the influence of prenatal
TiO2 NP exposure on the dopaminergic system was estab-
lished as increased levels of homovanillic acid, dopamine, 3,4-
dihydroxyphenylacetic acid, and 3-methoxytyramina hydro-
chloride in the prefrontal cortex and neostriatum of exposed
mice [55]. These findings indicate that TiO2 NPs can be carried
from the mother to the fetal brain, which ultimately has a
toxic effect on fetal brain development, leading to several
nervous system disorders. More in-depth studies are neces-
sary in order to understand fully the toxic effect of TiO2 NPs on
neurons in various stages of life, including during pregnancy
and early stages of development.
2.2. Zinc oxide NPs
Like TiO2, another metal-based NP is zinc oxide (ZnO), which
has broad uses and applications. ZnO is also white, thermally
stable, and a naturally occurring material. It can be used to
develop sunscreens, biosensors, food additives, cement, rub-
ber, ceramics, pigments, plastic, catalysts, and electronic
materials. ZnO shows antibacterial activities and in recent
years studies have also focused on the effect of nano-
particulate ZnO on various microorganisms [56,57].
In recent years, ZnO toxicity has been demonstrated both
in vitro and in vivo in various mammalian cells. Dissolved Zn2þ
from the NPs is responsible for the toxicity. ROSwere detected
in these studies and may have been responsible for the in-
flammatory effects associated with ZnO toxicity. The neuro-
toxic effect of ZnO has not been studied much. In one of the
early works, neurotoxicity of different-sized ZnO NPs
(10e200 nm) in mouse neural stem cells (NSCs) was investi-
gated. As determined by cell viability studies, ZnONPs showed
dose-dependent toxic effects towards NSCs. However no size-
dependent toxic effects on NSCs were found in this study [58].
Using confocal microscopy, transmission electron micro-
scopy, and flow cytometry, apoptotic cells were detected and
analyzed in this toxicity study. Like previous studies, the re-
sults indicate that ZnO NP toxicity originates from the dis-
solved Zn2þ in the culture medium or inside the cells [58]. The
effects of ZnO NPs on voltage-gated sodium and potassium
pumps and action potential generation have been studied by
Zhao et al [59]. The study on isolated rat hippocampal CA3
pyramidal neurons demonstrated that ZnO NP solution was
able to generate neuronal injury by inducing depolarization
through activation of voltage-gated sodium channels, and led
to higher Naþ influx and intracellular accumulation of Naþ
and Ca2þ, release of glutamate, and neuron excitability. ZnO
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intracellular Kþ level due to increased ion efflux [59]. An in vivo
toxicity study involving rats showed that intraperitoneal ZnO
altered synaptic plasticity, which changed spatial learning
and memory ability [60]. In that study, 20e80-nm ZnO NPs
(4 mg/kg body weight) twice weekly for 8 weeks were
administered to rats. ZnO NPs synthesized using the solegel
method and starch as a template have been tested for in vitro
cytotoxicity in neuro2A cells. A dose-dependent toxicity pro-
file was obtained, whereas nontoxic effects were seen at a
concentration < 6 mg/mL [61].
More studies have shown that the antibacterial activity or
adverse effects of ZnO NPs are partly due to the generation of
ROS [62e69], or causingmembrane damage through the direct
NPecell membrane interaction or generation of ROS [56,65], or
release of Zn2þ ions in the ZnONP suspensions [27,67]. Studies
in mammals have suggested that oral exposure of ZnO NPs
causes an increase in blood viscosity and pathological lesions
in the stomach, liver, kidney, pancrea, and spleen [70]. How-
ever, the potential hazards of high concentrations of manu-
factured nanoscale ZnO on the CNS need further
investigation.
2.3. Manganese oxide NPs
Manganese is an important metal. It is a trace element and
necessary for survival. In plants in photosystem II, a
manganese-containingmetal cluster is responsible for oxygen
generation from water activity and there are several enzymes
that use manganese for their activity [71]. Manganese has
found several other uses in our lives. Manganese is a major
component of making different types of steel and cast iron
[72]. Manganese chloride is used in batteries, disinfectants,
dyes, paint driers, and dietary supplements. Oxides of man-
ganese, such as manganese oxide (MnO), are used in colored
glass, ceramics, paints, textile printing, fertilizers, and in food
supplements and additives.Manganese dioxide (MnO2) is used
in batteries and may also be generated from the welding of
manganese alloys. Use of manganese-containing welding
rods is a major source of occupational exposure to welders.
Manganese tetroxide (Mn3O4) may be generated in situations
where other oxides of manganese are heated in air [73].
Methylcyclopentadienyl manganese tricarbonyl is used as an
antiknocking agent in some unleaded gasolines. The com-
pound is released to the environment during fuel combustion
in the form of manganese sulfate, phosphate, and oxides.
Farm workers who work with Maneb (manganese ethylene-
bis-dithiocarbamate) may also be exposed to a significant
amount of manganese [74].
As manganese is known for its neurotoxicity, toxicity
studies associated with manganese-containing nano-
materials provide a useful test case in the evaluation of
nanomaterial toxicity [75]. The occupational disease associ-
ated with manganese exposure and toxicity is known as
manganism. The disease in later stages resembles Parkinson’s
disease [76]. It has been found that if manganese is inhaled in
water-soluble and water-insoluble forms, it is translocated to
the brain, crossing the BBB via the olfactory nerve pathway
[77]. It has been found that, among many metals, manganese
is preferentially taken up via the olfactory nerve route [21,78].After nasal exposure to manganese oxide NPs (MnO, MnO2,
Mn2O3, and Mn3O4), the concentration of manganese in the
olfactory bulb, striatum, frontal, and other brain regions is
increased. Macrophage inflammatory protein-2, glial fibrillary
acidic protein, and neuronal cell adhesion molecule mRNA is
also increased in the olfactory bulb. The results indicate that
the olfactory neuronal pathway is efficient for translocating
inhaled manganese oxide as solid ultrafine particles to the
CNS and can result in inflammatory changes [24]. Although
absorption ofmanganese in the lungs is dependent on particle
size and solubility [24,79], for neuronalmanganese uptake and
further translocation into the CNS, dissolution of manganese
is not necessary. As mentioned earlier, major sources of ul-
trafine manganese oxide particles include the iron and steel
industries, battery production, ferroalloy production, and
power plant and coke oven combustion emissions [80]. Use of
glass, paints, and ceramics may also provide major sources of
manganese oxide. Methylcyclopentadienyl manganese tri-
carbonyl is presently used in gasoline, mainly in Canada and
Australia [81,82], and decomposition and oxidation of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
during combustion may release manganese oxide of nano-
particulate size into the environment. In all of these cases, the
most likely route of human exposure is through inhalation.
Toxicity of various manganese oxide nanomaterials has been
investigated in a neuronal precursor cell model. The Promega
CellTiter Aqueous One Solution Cell Proliferation (MTS) assay
was used to evaluate mitochondrial function in living cells
and the lactate dehydrogenase (LDH) assay was used to
quantify the release of the enzyme as a result of damage to the
cell membrane. Both assays indicated that manganese
toxicity was dependent on the type of manganese oxides and
their concentration. State of cell differentiation also contrib-
uted to varying NP toxicity. Manganese oxide NPs are
responsible for the generation of ROS and cell death due to
apoptosis, as revealed by flow cytometry. During cell division,
exposure to manganese oxide NPs results in elevated levels of
the transcription factor nuclear factor NF-kB. Such enhanced
levels of NF-kB mediate the cellular inflammatory response
[83]. In another study, Hussain et al [84] investigated the effect
of manganese oxide NPs (40 nm) on dopamine production in
PC12, neuronal phenotype cells. Manganese oxide NPs
induced depletion of dopamine and its metabolites dihy-
droxyphenylacetic acid and homovanillic acid in PC12 cells,
with a similar mechanism as Mn2þ [84]. In an in vivo study,
adult male Wistar rats were exposed to MnO2 NPs ofw23 nm
diameter. The experiment was a model study to understand
the inhalational risks associated with MnO2 NPs. MnO2 NPs
were instilled into the trachea for several weeks in daily doses
of 2.63 mg/kg and 5.26 mg/kg. The endpoints of functional
neurotoxicity (open field behavior and electrophysiology) and
general toxicity (body and organ weights) were investigated.
Animals treated with MnO2 did not gain weight after 6 weeks
exposure. High levels of manganese were detected in brain
and blood samples of the treated animals after 9 weeks
exposure. The open field behavior of treated rats showed
decreased ambulation and rearing, and increased local activ-
ity and immobility were observed. Electrophysiological
studies of animals treated for 9 weeks indicated a shift in
spontaneous cortical activity to higher frequencies,
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nerve conduction. Many of these neurofunctional and general
parameters were significantly correlated with the tissue
manganese levels. It can be concluded that the instilled
manganese in the NP form was absorbed and the NPs were
responsible for the neurotoxic effects [85].
The acute oral toxicity of MnO2 NPs and MnO2 bulk parti-
cles in female albino Wistar rats was investigated [86]. MnO2
NPs (45 nm) exhibited higher absorption and tissue distribu-
tion compared with MnO2 bulk particles. The histopatholog-
ical analysis revealed that MnO2 NPs caused alterations in the
liver, spleen, and brain. The neurotoxicity of 45-nmMnO2 NPs
in the brain and red blood cells, as determined through
acetylcholinesterase activity, was significantly inhibited at
doses of 1000 mg/kg and 500 mg/kg. MnO2 NPs (45 nm) dis-
rupted the physicochemical state and neurological system of
the animals through alterations in ATPases via the total
NaþeKþ, Mg2þ, and Ca2þ levels in the brain. Toxicity of Mn3O4
NPs was investigated in ST-14 rat striated neuroblasts, a
neuronal precursor cell model, using the MTS assay to eval-
uate mitochondrial function in living cells and the LDH assay
to quantify the release of the enzyme as a result of damage to
the cell membrane [87]. Both assays showed that the toxicity
ofMnwas dependent on the type ofmanganese oxide NPs and
their concentration, as well as the state of cell differentiation.
Following exposure to manganese oxide NPs, ROS were
generated, and flow cytometry experiments suggested that
cell death occurred through apoptosis. During exposure to
manganese oxide nanomaterials, increased levels of the
transcription factor NF-kB (which mediates the cellular in-
flammatory response) were observed.
2.4. Silver NPs
Silver is a bright, silvery white, soft metal that has been used
for thousands of years. Silver ornaments, utensils, and art
work have been around for a long time. Silver has monetary
value and silver coins and jewelry are considered as valu-
ables. Silver is used in large quantities as catalysts, mainly in
the production of ethylene oxide. It is also used industrially
for conductors, mirrors, and photographic applications. One
of the interesting properties of silver is its antibacterial and
antifungal activity. As a result, the use of nanoparticulate
silver is one of the fastest growing areas of commercial NP
applications [88]. Due to their excellent antibacterial proper-
ties, silver NPs have been used in food services, building
materials, textile industry, medical instruments, personal
care products, and washing machines [89]. Silver NPs (Ag
NPs) are used as room sprays, deodorants, wall paints, and
laundry detergents, and are also used for indoor air purifi-
cation and water detoxification [90,91]. As a result of these
widespread uses and exposure of silver NPs to humans, it is
likely that Ag NPs enter the body and accumulate in various
tissues and organs [92]. Previous research has indicated that
Ag NPs can accumulate in several organs, which includes the
kidney, liver, testis, lung, and brain [93].
In vitro studies have shown that Ag NPs are capable of
inducing toxicity in cells derived from a variety of tissues,
including liver, skin, vascular system, lungs, and reproductive
organs. Previous studies have shown that Ag NPs induce celldeath and oxidative stress in human skin carcinoma and
fibrosarcoma cells [94]. The same group have also reported
that Ag NPs can enter cells, causing DNA damage and
apoptosis in liver cells and fibroblasts [95]. Cell viability is
decreased when alveolar macrophages and lung epithelial
cells are treated with Ag NPs [96]. In vitro studies have shown
Ag NP toxicity in neural-like cell lines, such as PC12 cells,
which is a rat cell line with a neuronal-like phenotype [97].
It has been shown that Ag NPs could come across through
and be accumulated in brain microvessel vascular endothelial
cells. An in vitro BBB model composed of primary rat brain
microvessel vascular endothelial cells, it has been shown
crossing and accumulation capability of silver nanoparticles
[98]. Ag NPs can induce inflammation and affecte the integrity
of this BBBmodel, and be readily translocated to the brain [99].
Ag NPs can also induce BBB damage, astrocyte swelling, and
neuronal degeneration [100]. Ag NPs can translocate to the
brain using the nasopharyngeal system as a gateway during
inhalation exposure [17]. In vivo studies by Liu and coworkers
have shown the effects of Ag NPs on hippocampal synaptic
plasticity and spatial cognition in rats. Their studies have
revealed that intranasally administered Ag NPs induce
impairment of hippocampal function [101]. These results
suggest that Ag NPs cause neurotoxicity in humans and other
animals. More recently, a significant finding indicated that 7-
nm Ag NPs decreased motor activity and body weight in a
time- and dose-dependent manner after intravenous injec-
tion, suggesting that the nervous system may be targeted by
Ag NPs [102]. Yin and coworkers tried to establish the mech-
anism of Ag NP neurotoxicity both in vitro and in vivo using rat
cerebellar granule cells. Their studies indicated that Ag NPs,
depending on the caspase-activation-mediated signaling,
drastically decreased the survival of primary neuronal cells
through apoptosis coupled to oxidative stress [103].3. Iron oxide (FeO, Fe2O3, Fe3O4) NPs
Iron oxide or superparamagnetic iron oxide nanoparticles
(SPIONs) have become one of the most favorable and exciting
choices in both the industrial and biomedical fields, due to
their superparamagnetic property and other physicochemical
characteristics unique to nanomaterials. SPIONs (Feridex) are
small NPs composed of a Fe3O4 (magnetite) or Fe2O3 (maghe-
mite) core. Although maghemite is naturally ferromagnetic,
with the decreasing size (< 30 nm), it becomes super-
paramagnetic. Their potential application ranges from
biomedical imaging (magnetic resonance imaging, positron
emission tomography, or ultrasound as contrast agent), gene
and drug delivery, tissue regeneration, hyperthermia in can-
cer treatment, catalysis, and magnetic storage [104]. They are
extensively used specifically for brain imaging or brain-
targeted drug and gene delivery, due to their ability to move
across the BBB [105]. SPIONs are metal oxide NPs that have
been clinically approved, although recently they have been
taken off the market [106,107].
In spite of their desirable traits, there is a critical need to
investigate their toxicity both in vivo and in vitro. SPIONs have
already been shown to have potential toxicity that can lead to
altered gene expression, actin modulation, interference with
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generation, and disruption of iron homeostasis [108]. Ac-
cording to the recent findings, environmental factors are a
major contributor to the development of neurodegenerative
diseases, such as Parkinson’s disease and Alzheimer’s disease
[109]. Peters et al [110] have emphasized the significance of
oxidative stress generated by NPs in the brain, along with the
evaluation of the possible connection between long-term NP
exposure and neurodegenerative disease. With increased use
of Fe3O4 NPs in industry and biomedical sciences, the risk
related to occupational exposure has escalated considerably.
Involvement of ultrafine particulate materials in polluted air
leads to protein fibrillation. Fibrillation of specific proteins, for
example, Ab42 and a-synuclein, may play a role in the devel-
opment of Alzheimer’s disease and Parkinson’s disease [111].
SPIONs have further been shown to form a corona with
plasma proteins. This corona can lead to several toxic side
effects because the initial cellular interaction of magnetic
nanoparticle (MNP) changes lead to downstreammodification
of cellular and tissue interaction [112,113]. In 2007, Pisanic et al
[114] used PC12 cells as a quantifiable in vitromodel system to
study the toxic effect of anionic Fe3O4 MNPs in a dose-
dependent manner. In that study, it has been established
that when PC12 cells were exposed to the anionic MNPs at an
increasing concentration ranging from 0.15mM to 15mM iron,
they lost their viability and were unable to generate normal
neurite growth in the presence of nerve growth factor. They
have concluded that the anionic MNPs were possibly inter-
fering with transcriptional regulation and protein synthesis,
for example, Growth associated protein (GAP)-43 leading to
cellular death and phenotypic changes.
In 2009, Wang et al [115] discussed the ability of submicron
level Fe3O4 NPs to be transported to the brain via the olfactory
nerve pathway, leading to oxidative-stress-related damage in
the brain. They also discussed changes in the ultrastructure of
the olfactory bulb nerve cells. Recently, Wu et al [116] have
focused on the neurotoxicity of iron oxide NPs in the rat brain
(in vivo). The study investigated the effect of uptake and
retention of Fe3O4 NPs in rat brain hippocampus and striatum,
including oxidative injuries. The olfactory bulb, striatum, and
hippocampus seemed to be the main sites for Fe3O4 NP
deposition after intranasal instillation [117]. Approximately
80% of NPs were still found in the striatum at 7 days after
instillation and about 50% were found in both the striatum
and hippocampus after 14 days. The striatum in the instilla-
tion groups exhibited comparatively more susceptibility to
oxidative stress, as indicated by increased levels of H2O2 and
decreased Glutathione peroxidase (GHS-PX) activity in the
control group at 7 days after exposure. The group also inves-
tigated the effect of Fe3O4 NPs in PC12 cells in vitro. The PC12
cells showed dose-dependent cytotoxicity, as measured by
LDH release and MTT assay, demonstrating membrane
disruption and mitochondrial enzyme activity, respectively.
The oxidative stress was also evident by the reduced GSH-PX
and superoxide dismutase activity, and increased ROS level
and lipid peroxidation. Fe3O4 NPs also had a substantial
cytotoxic effect on PC12 cells by modulating the cell cycle and
inducing apoptosis. JNK is usually activated by oxidative
stress andmodulates apoptosis, neurodegeneration, cell cycle
control, and cellular proliferation [118]. The cells alsoexhibited phosphorylation of p53 protein at ser15 position and
elevated levels of bax and bcl-2 proteins upon exposure to
NPs.
It has been demonstrated that intranasally instilled Fe2O3
NPs are transported into the brain via the olfactory route [119],
and additional investigation has beenmade of the size-related
effect. After a single intranasal exposure of 21-nm Fe2O3 NPs,
there was a significant increase in iron content in almost all
the brain regions, from the olfactory bulb, hippocampus, ce-
rebral cortex, and cerebellum to the brainstem [120]. However,
a single intranasal exposure of 280-nm Fe2O3 NPs led to a
significant increase in iron content only in the olfactory bulb
and hippocampus, with no significant alteration of iron con-
tent in other brain regions. At 30 days after instillation of 280-
nm Fe2O3 NPs in mice, the iron content in the olfactory bulb
and hippocampus also increased but was lower than that in
mice treated with 21-nm Fe2O3 NPs.
It is widely known that brain iron accumulation is associ-
ated with the oxidative stress induced by the formation of the
highly reactive OH via the Fenton reaction [121e123]. The
excess iron in the brain suggests an association with the
oxidative stress response. The generation of ROS is a well-
established paradigm to explain the toxic effects of NPs [40].
It has been demonstrated that intranasal exposure of iron
oxide NPs causes a certain degree of oxidative stress response
in mouse brain [119]. Significant oxidative stress responses in
the brain of mice have also been observed after intranasal
exposure of 21-nm and 280-nm Fe2O3 NPs [124]. Alterations of
iron and zinc levels in the brain are more evident in mice
exposed to nano-sized than submicron-sized Fe2O3. Further-
more, the strong positive correlation between the iron and
zinc levels in the sub-brain regions may contribute to the
understanding of zinc homeostasis in the brain after Fe2O3
particle inhalation.
The biomarkers of oxidative stress, activity of nitric oxide
synthases, and release of monoamine neurotransmitters in
the brain have been studied as well [115]. It was shown that
significant oxidative stress was induced by the two sizes of
Fe2O3 NPs. The activities of GSH-PX, copper, zinc superoxide
dismutase, and constitutive nitric oxide synthase were
significantly elevated and the total glutathione and gluta-
thione/glutathione disulfide ratio were significantly decreased
in the olfactory bulb and hippocampus after treatment with
nano- and submicron-sized Fe2O3 particles. The nano-sized
Fe2O3 generally induced greater alteration and a more signif-
icant doseeeffect response than the submicron particles did.
Transmission electron microscopy showed that nano-sized
Fe2O3 treatment induced some ultrastructural alterations in
nerve cells, including neurodendron degeneration, membra-
nous structural disruption, and increased lysosomes in the
olfactory bulb, dilation in the rough endoplasmic reticulum,
and increased lysosomes in the hippocampus. The results
indicated that intranasal exposure of Fe2O3 NPs could induce
more severe oxidative stress and nerve cell damage in the
brain than the larger particles did.
Fe3O4 NPs also exert cytotoxic effects by influencing the
cell cycle and apoptosis [116]. For example, cells are arrested
at the G2/M phase after 24 hours exposure to NPs. Arrest at the
G2/M phase provides time for these cells to instigate DNA
repair and delay cell death. However, cells with impaired DNA
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Fe3O4 NPs are deposited and retained in the striatum after
intranasal instillation, and the NPs may then cause oxidative
damage in the striatum. The results of in vitro studies on
dopaminergic neurons have demonstrated that Fe3O4 NP
exposure decreases cell viability and induces marked oxida-
tive stress. Furthermore, Fe3O4 NPs mediated apoptosis
signaling pathway included JNK and c-Jun phosphorylation,
p53 phosphorylation, Bax upregulation, Bcl-2 downregulation,
and apoptosis.
3.1. Copper and copper oxide NPs
Copper is one of the essential trace elements for energy pro-
duction in biological systems. Copper is a requirement for the
synthesis of different enzymes, including cytochrome c oxi-
dase, superoxide dismutase, tyrosinase, lisyl oxidase, and
cupro-protein [125,126]. Copper is also responsible for stimu-
lating the production of neurotransmitters such as epineph-
rine and norepinephrine in the brain and can be found there at
a high concentration [127]. However, at higher than normal
levels, unbound copper become toxic to the human body
because it disrupts homeostasis. Its redox activity can give
rise to ROS, leading to oxidative stress and modification of
protein, lipid, and nucleic acid [128,129]. Compounds of cop-
per such as copper oxide (CuO) NPs have found a broad use in
various areas. CuO NPs are used in inks, lubricants, coatings,
semiconductors, heat transfer fluids, antimicrobial prepara-
tions, and intrauterine contraceptive devices [130]. Copper-
based NPs are used as lubricant additives because they
reduce friction and wear, and worn surfaces can be repaired
by an addition of copper NPs in lubricants. As more copper
NPs are currently in use, it is likely that human exposures to
copper NPs will increase gradually.
Due to their nanolevel size, CuONPs are capable of crossing
the BBB and pose a threat to the CNS. Studies have shown that
copper NPs can cause BBB dysfunction, swelling of astrocytes,
and neuronal degeneration once introduced into the blood-
stream [1,131]. Li et al [132] showed neurotoxicity of CuO NPs
in a dose-dependentmanner in H4 neurogiloma cells using an
automated image analysis technique.
Primary cultures of dorsal root ganglion of neonatal rat
pups were investigated to measure neurotoxicity of copper
NPs of varying size and concentration by Prabhu et al [133].
After exposured to 10e100mM copper NPs (40 nm, 60 nm, and
80 nm) for 24 hours, the neurons started to develop vacuoles
and became detached from the substratum. They also
exhibited disruptive neurite growth. LDH and MTT assays
have also shown the significant toxicity of copper NPs, and the
smaller size is associated with higher toxicity.
The whole-cell patch-clamp technique was used to study
the influence of CuO NPs on voltage-dependent potassium
current in acutely isolated rat CA1 pyramidal neurons of the
hippocampus [134]. Although the CuO NPs did not have a
significant effect on the outgoing potassium current, they did
inhibit the delayed rectifier potassium current at a relatively
high concentration. CuO NPs shifted the inactivated curve of
rectifier potassium current negatively but did not show any
significant effect on transient outgoing potassium current.
These blockades of the potassium current might inhibit thenormal functional activity of nerve cells. In another study,
Trickler et al [135] has determined the effect of copper NPs on
induction of proinflammatory mediators, followed by their
influence on rat brain microvessel endothelial cells. At a low
dosage, the copper NPs enhanced cellular proliferation,
whereas at a high concentration, they started to express
toxicity. NP exposure increased prostaglandin E2 release.
Extracellular levels of TNF-a and IL-1b were considerably
higher in the exposed cells. This resulted in the disruption of
cerebral microvasculature by increasing its permeability.
According to Karlsson [136], nano-CuO is highly toxic when
compared with other metal oxide NPs. However, few studies
have investigated the direct effects of nano-CuO on neuro-
toxicity and the potential mechanisms involved in these
effects.
A study explored the potential neurotoxicity of nano-CuO
on ion channels of neuron, voltage-dependent sodium current
(INa) in rat hippocampal slices with whole cell patch-clamp
technique [137]. The results showed that nano-CuO inhibited
the peak amplitude of INa, which might have decreased
intracellular Naþ concentration due to decreased Naþ influx.
This could inhibit the exchange of Naþ for Ca2þ by NaþeCa2þ
exchangers [138]. The exchanger was shown to generate in-
ward current during the repolarization phase of the action
potential [139], thus, the effect on INa could contribute to the
change in action potential shape by nano-CuO.
It is well established that voltage-gated sodium current
(VGSC) plays a role in neurotransmitter release [140]. Thus, the
effects of nano-CuO on INa also mean that modulation may
produce functional effects on neurotransmission in the CNS.
It has been shown that nano-CuO produces a hyperpolarizing
shift in the activation curve. The S4 segment in a subunit of
VGSCs contains 4e8 positively charged residues at three res-
idue intervals. They serve as voltage sensors and initiate the
voltage-dependent activation of VGSCs by moving outward
under the influence of the electric field [141,142]. The results
suggest an effect on the S4 segment of the activation gating,
resulting in conformational changes of the channel. The
findings also confirm that the effects of nano-CuO on hippo-
campal neurons are mediated through activation of
ROSeINaeaction potential signaling cascades and are inde-
pendent from the G-protein pathway. These results show the
primary mechanisms underlying nano-CuO-induced INa
amplitude inhibition and improve our understanding of nano-
CuO neurotoxicology.
To determine the potential neurotoxicity of CuO NPs,
human SH-SY5Y neuroblastoma and H4 neuroglioma cells
were exposed at a concentration range of 0.01e100 mM for 48
hours [132,143]. The data indicated that exposure of CuO NPs
induced differential toxic effects in both SH-SY5Y and H4
cells, and the cells had dose-dependent toxic responses to the
CuO NPs. The toxic effects of CuO NPs were also investigated
in a semiadherent, fast-growing, mouse neuroblastoma cell
line (N2A cells), to provide a better understanding of the
toxicological risks of CuO NPs in future nanotechnology de-
velopments [144]. N2A cells were less sensitive to CuO NP ef-
fects than other cultured cells were. The lower sensitivitymay
have been due to the agglomeration of CuO NPs in the culture
medium, which resulted in an average particle size > 300 nm.
Agglomeration of CuO NPs reduced surface-specific effects
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 2 ( 2 0 1 4 ) 1 4 7e1 6 0154specific to nanoscale materials, and increased the contribu-
tion of particle solubilization in the toxic response induced in
N2A cells. Agglomerated CuO NPs induced both cytotoxic and
genotoxic effects in N2A cells.
3.2. Aluminum oxide (alumina, Al2O3) NPs
In recent years, the areas of nanotechnology and nano-
medicine have expanded rapidly, aluminum oxide (alumina)
NPs, having good electric and abrasive properties, are widely
used as abrasive agents or insulators in motor vehicles, elec-
tronics, energetics, exterior coatings, personal care products,
scratch-resistant coatings, alloys, and sensors [145]. This has
led to increased human exposure to aluminum oxide NPs
(nano-alumina).
An in vivo study in ICRmice aimed to investigate the effects
of nano-alumina, with a focus on the effects on neuro-
behavioral defects and possible mechanisms of action. It
showed that nano-alumina induced apoptosis via increased
caspase-3 gene expression and impaired spatial learning
behavior, which suggests that mitochondrial impairment
plays a key role in the neurotoxicity of nano-alumina [146].
The research could help to understand the underlying
mechanisms of toxicity of nano-alumina, particularly with
respect to neurobehavioral function. The authors declared
that impairment of themitochondria played an important role
in the neurotoxicological effects of nano-alumina and might
be a direct cause of neurobehavioral defects.
The possible neurotoxic effects of nano-alumina and
bulk alumina have been compared in nematodes [147]. The
relatively large surface area of nano-alumina compared
with bulk alumina might also explain the differences in
toxicity between nano-alumina and bulk alumina. The
decrease in locomotive behavior in nematodes chronically
exposed to nano-alumina was associated with both an in-
crease in ROS generation and disruption of ROS defense
mechanisms. Drosophila was used as another model organ-
ism to explore the effects of nano-alumina on the CNS [148].
The rhythmic and electrophysiological activities in the
antennal lobe of Drosophila were recorded using patch
clamps. Fifteen minutes after application of nano-alumina,
the average frequency of spontaneous activity was signifi-
cantly decreased compared with that of the control groups.
The results indicate that nano-alumina might have adverse
effects on the CNS in Drosophila.
The hypothesis that nano-alumina can affect the BBB and
induce endothelial toxicity has been proposed [149]. In the
first series of experiments, human brain microvascular
endothelial cells were exposed to nano-alumina and control
NPs in dose- and time-responsive manners. Treatment with
nano-alumina markedly reduced human brain microvascular
endothelial cell viability, altered mitochondrial potential,
increased cellular oxidation, and decreased tight junction
protein expression as compared to treatment with control
NPs. Alterations of tight junction protein levels were pre-
vented by cellular enrichment with glutathione. In the second
series of experiments, ratswere infusedwith nano-alumina at
a dose of 29 mg/kg and brains were stained for expression of
tight junction proteins. Treatment with nano-alumina resul-
ted in marked fragmentation and disruption of integrity ofclaudin-5 and occludin. The results indicate that the cere-
brovasculature could be affected by nano-alumina. In addi-
tion, the data indicate that alterations of mitochondrial
function might be the underlying mechanism of nano-
alumina toxicity.
As far as the assessment of toxicological properties of
nanoparticles is concerned, it is important to know whether
cultured neural cells take up NPs, and if so, what mechanisms
are involved [150]. Ultrastructural examination has shown
that nano-alumina penetrates the cell membrane and that
some particles are engulfed by the cells and mainly accumu-
lated in the cytoplasm. It has been demonstrated that the NPs
entering the cells are likely to have an effect on cellular
function. Bulk-alumina-treated cells show apoptotic charac-
teristics, whereas nano-alumina-treated cells demonstrate
both apoptotic and necrotic morphological changes. Photo-
micrographs show that the vesicles with individual particles
and aggregates remain in the cytoplasm and the nucleus.
According to transmission electron micrographs, NPs form
aggregates inside the lysosomal vesicles and their internali-
zation in lysosomal bodies is arranged in a perinuclear
fashion. The presence of an elevated amount of lysosomes
might reflect enhanced phagocytosis of exogenous particles.
Microglia and astrocytes are dominant glial and major
immune cells in the CNS. They are sensitive to changes in the
microenvironment of the CNS and are rapidly activated in
almost all conditions that affect normal neuronal functions.
Activation of microglia and astrocytes in the cortex and hip-
pocampus following peripheral administration of nano-
alumina have been analyzed in SpragueeDawley rats [151].
There was significant glial activation induced in rat brain after
nano-alumina administration.
3.3. Silicon dioxide (silica) NPs
Silica (SiO2) NPshave beendeveloped formechanical polishing,
additives to food and cosmetics, and have various applications
in biomedical fields, including diagnosis, optical imaging, tar-
geted drug delivery for the CNS, cancer therapy, and controlled
drug release for genes and proteins. In particular, being
considered more biocompatible than other imaging NPs, silica
NPs are emerging as ideal materials for medical applications.
For applications of potential drug delivery, imaging, and di-
agnostics in the CNS, silica NPs are also beingmodified or used
for coating or stabilization of other optical materials. However,
to date, little is known concerning the potential adverse effects
on the brain associated with exposure to silica NPs.
Research has indicated that silica NPs via intranasal
instillation enter the brain and show a distinct pattern of
biodistribution, and are especially deposited in the striatum,
except for the olfactory bulb [152]. Such an accumulation
could result in oxidative stress, inflammatory changes, and
functional damage of the striatum. In addition, silica NPs
appeared to induce depleted dopamine in the striatum, and
the main contribution was downregulation of tyrosine hy-
droxylase protein.
In vitro studies on dopaminergic neurons have demonstrated
that silica NPs have marked cytotoxic effects and oxidative
stress activity against PC12cells [152]. Furthermore, activationof
the p53 pathway is involved in the mechanism of the silica-NP-
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dopamine levels is most likely attributable to the reduction of
dopamine synthesis. The authors have claimed that although
extrapolation of the animal effects to humans remains a chal-
lenge, their results for the neurotoxic effect on rat brains could
be suggestiveofhumanexposure,becausedifferent speciesmay
respond differently to the same substance.
Another study demonstrated that exposure to 300 ppm
silica NPs in differentiating cells showed less cytotoxicity than
in undifferentiated cells [153]. Silica NPs at 100 ppm had no
significant effect on the viability of either undifferentiated or
differentiating neuroblastoma (SH-SY5Y) cells. Neurite
outgrowth in differentiating cells after 48 hours exposure to
100 ppm silica NPs was not significantly changed. Thus, silica
NPs appeared to have no effects in the early initiation of
neurites. Although the production of ROS was not induced,
neurotoxicity induced by silica NPs may be the result of
increased DNA damage, apoptosis, and cell cycle arrest in
undifferentiated and differentiating cells, which is indepen-
dent of neuronal differentiation of SH-SY5Y cells.4. Carbon-based nanomaterials
Owing to their unique chemical and physical properties,
carbon-basednanomaterials have a potential use in a variety of
biomedical applications, including early diagnosis of cancer,
imaging, targeted photothermal therapy, drug delivery, and
tissue engineering. Based on the shape, organic carbon-based
nanomaterials are categorized as carbon nanotube, fullerene,
graphene, or carbon NPs. Carbon nanotubes are one-
dimensional forms of graphitic material and are present in
many forms, depending on the number of graphene sheets
used: single-walled carbon nanotubes, double-walled carbon
nanotubes, andmulti-walledcarbonnanotubeswithdiameters
of 1e2 nm and lengths of 0.05e1 mm. Graphene has similar
chemical compositionandcrystallinestructurewithaflat sheet
with a single layer or multilayer graphene with several layers.
The fullerenes (C60) are named after Richard Buckminster
Fuller as buckminsterfullerene, or the “bucky ball”. This allo-
trope of carbon consists of 60 carbon atoms joined together to
form a cage-like structure. C60 is soluble in aromatic solvents
(e.g., toluene or benzene), but insoluble in water and alcohol.
However, C60 can be functionalized (e.g., witheOH,eCOOH, or
eNH2) to increase its hydrophilicity. By contrast, aqueous
fullerene aggregates can be generated by mixing pure C60 in
wateror throughsolvent extraction. Some fullereneshavebeen
shown to inhibit human immunodeficiency virus (HIV) activity
through inhibiting an HIV-associated protease, an essential
enzyme for viral survival. It has been reported that some ful-
lerenes can interact with biological membranes to elicit anti-
microbial action, antitumor activity, enzyme inhibition, DNA
photo cleavage, and neuroprotective activity via antioxidant
actions. At present, fullerenes are commercially used in prod-
ucts including fuel cells, semiconductors, andproduct coatings,
for example, bowling ball surfaces.
Studies of carbon nanomaterials have indicated the po-
tential neurotoxic effects after inhalation or systemic expo-
sure. Oberdo¨rster and co-workers [17] showed that inhalation
of elemental 13C NPs of 36 nm by rats, which were exposed for6 hours whole-body exposure, led to a significant and persis-
tent increase in the accumulation of 13C NPs in the olfactory
bulb, and the NP concentration gradually increased. A recent
study has shown that different shapes of carbon nano-
materials elicit different toxicity in neuronal culture models.
Specifically, pure graphene is less toxic than highly purified
single-walled carbon nanotubes in a concentration-
dependent manner after 24 hours exposure of PC12 cells,
involving the apoptosis pathway [154]. Subsequently, the
impact of surface functionalization on the toxicity of carbon
nanotube has been demonstrated using the same culture
model. Carbon nanotubes with surface-coating polyethylene
glycol are less toxic than uncoated carbon nanotubes, by
measuringmitochondrial function andmembrane integrity. A
mechanistic study has shown that oxidative stress is involved
in this toxic pathway, with surface coating playing an
important role [155]. It has been reported that 14-nm carbon
black particlesmight translocate to the olfactory bulb through
olfactory neurons, resulting in the activation of microglial
cells, which induces proinflammatory cytokines and chemo-
kines, suggesting an inflammatory response [156]. Additional
systematic evaluations and mechanistic in vivo studies are
needed to understand the effect of surface coating on the
biocompatibility of these carbon-based nanomaterials prior to
use in humans.5. Future perspectives
Physical and chemical characterization is considered to be the
key element in assessing the neurotoxicity of nanomaterials.
The nanomaterials used in the study require a comprehensive
physicochemical characterization before during, and after the
biological testing models are exposed to nanomaterials. As
mentioned previously, the size, size distribution, purity,
shape, crystal structure, composition, surface coating, surface
charge, and surface reactivity may result in a different dis-
tribution, accumulation, and transport of the nanomaterials
to the target organs, as well as across the BBB. Research
findings are meaningless for hazard identification in the
absence of adequate evaluation of the physical and chemical
properties of nanomaterials. For example, impurities that
contaminate the nanomaterials being tested may contribute
most to neurotoxicological responses. The dissolution of
metal ions from metal oxide nanomaterials may play an
important role in neurotoxicity. The size or surface charge of
nanomaterials might change the biokinetics of the nano-
materials, resulting in different pharmacological or toxico-
logical actions in biological systems. However, batch-to-batch
inconsistency is a major challenge when nanomaterials are
produced by different manufactures/laboratories.
The exposure dose level should be carefully considered
when laboratory animals or in vitro models are exposed to
nanomaterials. The practically exposure level to human
should be used as a reference when calculateing the relevant
dose exposed to the animals or in vitro models. This will
support studies for understanding the dosimetry in the ner-
vous system. The characteristics of the nanomaterials should
also be considered in physiologically based pharmacokinetic
modeling to better predict the environmental hazard of the
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neurotoxicity assessment of nanomaterials still exists, and
further in vivo studies will be considered as an urgent demand
in the future.
Appropriate doseeresponse research should be considered
in neurotoxicological studies. Recent inhalation studies have
shown that the surface area or particle number, instead of the
nanomaterials mass, is considered as the major dosimetry
unit in term of the dose-response relationship. Cellular or
target organ dose will provide a better understanding of the
neurotoxicological responses, because the physical properties
might change quickly in the biological system under the
experimental conditions. Sensitive and specificmethods need
to be developed to quantify the nanomaterials, including
metal NPs or carbon-based nanomaterials. The nanomaterials
may interfere with the enzymatic assay during the measure-
ment of neurotransmitters (such as acetylcholine or dopa-
mine) using traditional methods. Therefore, the traditional
approaches using chemicals should be carefully validated
because they are used in nanoneurotoxicological studies.Conflicts of interest
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